Ameriprise Financial Inc Oric Pharmaceuticals, Inc. Transaction History

Ameriprise Financial Inc

  • $375 Billion
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$7.52 - $11.9 $83,539 - $132,197
11,109 New
11,109 $113,000
Q3 2020

Nov 16, 2020
SELL
$19.5 - $31.26 $214,461 - $343,797
-10,998 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$25.68 - $38.12 $282,428 - $419,243
10,998 New
10,998 $371,000

Others Institutions Holding ORIC

# of Institutions
132
Shares Held
67.3M
Call Options Held
404K
Put Options Held
6.4K
View Full List

About Oric Pharmaceuticals, Inc.

ORIC Quotes by TradingView
  • Ticker ORIC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,576,700
  • Market Cap $304M
  • Description
  • ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...
More about ORIC
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email